Cannabidiol

Global Cannabidiol Market to Reach US$12.4 Billion by 2032

The global market for Cannabidiol estimated at US$3.4 Billion in the year 2025, is expected to reach US$12.4 Billion by 2032, growing at a CAGR of 20.1% over the analysis period 2025-2032. Hemp, one of the segments analyzed in the report, is expected to record a 21.4% CAGR and reach US$8.1 Billion by the end of the analysis period. Growth in the Marijuana segment is estimated at 18.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 26.6% CAGR

The Cannabidiol market in the U.S. is estimated at US$1.1 Billion in the year 2025. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2032 trailing a CAGR of 26.6% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.8% and 18.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 17.7% CAGR.

Global Cannabidiol (CBD) Market – Key Trends & Drivers Summarized

Why Is Cannabidiol (CBD) Gaining Global Popularity?

Cannabidiol (CBD) has rapidly gained popularity across the globe due to its wide range of health benefits and therapeutic applications, particularly in managing chronic pain, anxiety, epilepsy, and other medical conditions. Unlike tetrahydrocannabinol (THC), the psychoactive component of cannabis, CBD does not produce a "high," making it a more appealing option for those seeking relief from various ailments without the mind-altering effects of marijuana. Derived from the cannabis plant, CBD is available in various forms, including oils, capsules, edibles, creams, and tinctures, making it accessible to a diverse consumer base. Its rise is largely driven by increasing consumer interest in natural and alternative treatments, as well as growing awareness about the potential health benefits of cannabinoids.

The widespread legalization of cannabis for medical and recreational use in several countries has further accelerated the demand for CBD products. With consumers increasingly turning to plant-based and holistic remedies, CBD has become a preferred option for those seeking relief from stress, inflammation, sleep disorders, and other health concerns. Research into CBD`s potential to manage neurological conditions, such as epilepsy, as evidenced by the FDA`s approval of Epidiolex (a CBD-based drug for epilepsy treatment), has added credibility to its therapeutic potential, fueling growth in the global market.

How Are Technological Advancements Shaping the CBD Industry?

Technological advancements in the extraction, formulation, and production of CBD are significantly transforming the market. The development of more efficient extraction methods, such as CO2 extraction, has allowed manufacturers to produce higher-purity CBD products that retain the beneficial compounds of the cannabis plant while eliminating unwanted substances. This improvement in extraction technology ensures that consumers have access to safer, more consistent, and more potent CBD products. Moreover, innovations in nanoemulsion technology are enabling the production of water-soluble CBD, which enhances bioavailability and absorption, making CBD products more effective at lower doses.

Another notable advancement is in the area of product development and customization. As consumer demand for CBD continues to grow, manufacturers are creating a diverse range of CBD-infused products, from beverages to skincare lines, targeting specific consumer needs. The rise of CBD edibles, beverages, and personal care products highlights how manufacturers are innovating to cater to different markets. Additionally, advancements in testing and analytics tools have improved the safety and regulation of CBD products, ensuring that they meet the necessary quality standards. As technology continues to evolve, it will likely lead to further innovations in product formulation and delivery methods, broadening the scope of CBD`s application in health and wellness.

How Are Changing Consumer Preferences Influencing the CBD Market?

Changing consumer preferences, particularly the shift toward natural and wellness-oriented products, are playing a pivotal role in shaping the CBD market. Today’s consumers are more health-conscious and are actively seeking out natural alternatives to conventional pharmaceuticals. CBD fits this profile perfectly, as it is derived from plants and is often marketed as a natural remedy for various health issues. The growing trend toward self-care and wellness has seen CBD products increasingly integrated into daily routines, such as using CBD oils or creams for relaxation, pain management, or skin care. The demand for clean-label, organic, and non-GMO CBD products is also on the rise, as consumers seek out products that align with their values of sustainability and health.

Additionally, the trend of personalization in healthcare and wellness is driving the demand for customized CBD solutions. Consumers are looking for CBD products tailored to specific health conditions, lifestyles, or preferences, such as CBD-infused products for stress relief, athletic recovery, or enhanced sleep. This growing interest in personalized wellness solutions has prompted companies to expand their product lines and create targeted marketing strategies to meet these demands. Moreover, as more consumers become educated about the potential benefits of CBD, its acceptance as a mainstream supplement is increasing, further driving market growth.

Growth in the Cannabidiol (CBD) Market Is Driven by Several Factors

The growth in the cannabidiol (CBD) market is driven by several factors, including increasing consumer awareness of its health benefits, the legalization of cannabis in various regions, and the expansion of product offerings. The rising demand for natural alternatives to traditional medications is a significant driver, as more consumers are turning to CBD for pain relief, anxiety management, and other health conditions. The growing body of scientific research supporting the therapeutic potential of CBD, particularly for conditions like epilepsy, chronic pain, and inflammation, is also encouraging wider adoption of CBD products. 

Legalization and regulatory changes are another major factor fueling market growth. The relaxation of laws governing the use of CBD in North America, Europe, and parts of Asia has created new opportunities for market expansion. In countries where cannabis and CBD are legally accessible, the market is experiencing rapid growth, with consumers increasingly exploring the potential uses of CBD in everything from dietary supplements to pet products. Additionally, the entry of major retail chains into the CBD market, along with online distribution channels, has made CBD products more accessible to consumers globally. Furthermore, the rising interest in wellness and holistic health, along with the increasing use of CBD in the beauty and personal care industry, is contributing to the sector`s growth. As the stigma around cannabis continues to fade and more consumers prioritize wellness and alternative treatments, the CBD market is expected to see sustained growth, with new product innovations and expanded applications driving demand across a variety of industries.

SCOPE OF STUDY:

The report analyzes the Cannabidiol market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Source (Hemp, Marijuana); Distribution Channel (B2B, B2C); End-Use (Medical, Personal Use, Pharmaceuticals, Wellness)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• ABcann Medicinals, Inc.
• Aphria, Inc
• Aurora Cannabis
• Canopy Growth Corporation
• CBD LION
• CBDfxBota
• CBDistillery
• cbdMD
• GW Pharmaceuticals, plc
• Kazmira
• Maricann, Inc. (Wayland Group Corporation)
• Medixcbd
• Medterra
• NuLeaf Naturals
• Organigram Holding, Inc.
• The CBD Company
• The Cronos Group
• Tikun Olam
• Tilray

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more